Engineering novel biosensors for unmet needs

Human Healthcare

Helping couples grow a family by allowing women to assess their fertility health

Animal Healthcare

Providing farmers a tool to manage their herd and time animal reproduction

Environmental Wellness

Evaluating the health of our environment to revitalize fragile ecosystems

BioSens8 Team

Uroš Kuzmanović

CEO/Board Member

Genomics, SynBio, Sensors

James Galagan, PhD

President/Chairman/Scientific Advisor/Board Member

Genomics, Sensors, Devices

Douglas Densmore, PhD

Scientific Advisor/Board Member

Automation & SynBio

Roman Addokhi

Senior Scientist

Sensors & Devices

Catherine Klapperich, PhD

Scientific Advisor

Diagnostics & Devices

Karen Allen, PhD

Scientific Advisor

Protein Engineering

News

  • 12/24/2021

BioSens8 was accepted into the Nucleate accelerator 2022 cohort! We'll be working through Spring engaging with clinical and business mentors to grow our company.

  • 11/9/2021

BioSens8 is participating as a host company in Brown University's PRIME graduate program in order to discover potential markets we can enter with our IP.

  • 10/12/2021

BioSens8 engaged in NSF's Beat the Odds Bootcamp in order to complete even further customer discovery in the human fertility market segment.

  • 9/20/2021

BioSens8 is participating as a host company in the Boston University Questrom business school class, Bench to Bedside, to discover potential markets our platform technology can be applied toward and then follow with customer discovery!

  • 9/14/2021

BioSens8 is participating as a host company in the MIT Sloan business school class, E-Lab, to diver deeper into unmet needs and identify the value propositions of our progesterone biosensor in the FemTech space!

  • 7/20/2021

NSF has awarded our STTR Phase I proposal for developing a novel progesterone biosensor for monitoring fertility health! We're delighted to have the support of NSF, the funds will be used for achieving technical milestones required for commercialization.

  • 6/28/2021

BioSens8 was selected from more than 3000 global applicants to join the MassChallenge 2021 cohort! We're excited to partake alongside 228 other startups!

  • 5/3/2021

Boston University has awarded Dr. James Galagan with the Ignition Award! The funds will be used for R&D work toward bringing a novel animal healthcare biosensor to market.

  • 4/7/2021

BioSens8 was awarded the second largest prize at the M2D2 $200K Challenge! We're thrilled to be supported by M2D2 with a cash award! Check out our award winning pitch.

  • 4/7/2021

BioSens8 pitched in front of a panel of Med Tech judges including industry leaders, investors, and practitioners for the BU Ignition Award.

  • 3/8/2021

BioSens8 was selected as a M2D2 $200K Finalist! We were one of 15 startups (out of more than 170 worldwide entrants) in the running for $200,000 in in-kind services and research support from sponsors that include UMass Lowell, Amgen, Boston Scientific, Johnson & Johnson Innovation, Massachusetts Life Sciences Center, Mintz, and others.

The virtual M2D2 $200K Challenge Finalist Pitch-off being hosted through Zoom on Wednesday, March 24th. Register for free and watch us pitch here!

  • 3/4/2021

BioSens8 successfully submitted a NSF STTR Phase I application.

  • 2/11/2021

BioSens8 was selected as a Boston University Ignition Award finalist! Our full proposal was well received by the Ignition Review Committee, made up of outside representatives (investors, industry) and BU academics. As a finalist, BioSens8 will present for the Ignition Award on 4/7/2021.

  • 12/16/2020

BioSens8 officially incorporated.

  • 11/23/2020

BioSens8 was selected to submit a full proposal for the Boston University Ignition Award! The Ignition Award program is designed to help Boston University researchers bring their projects with commercial potential to the next level.

  • 10/15/2020

BioSens8 was accepted to partake in the NSF NE I-Corps Spark Program to perform customer discovery!

Contact

If you wish to invest, become a business partner, license our technology or require a biosensor solution

please contact: uros@biosens8.com